Cannabis Biotech In Talks With Research Chemist to Explore Transmucosal Delivery

This project is part of the company’s strategy to develop a wider variety of delivery methods directed towards a growing, diverse patient base.

FLORIDA: Puget Technologies announced its subsidiary, Cannabis Biotech, is in talks with a research chemist to explore the development of an exclusive cannabis-based metered-dose transmucosal delivery platform. The transmucosal system is an effective means to introduce treatments across the mucous membrane and is a well-established and accepted system of administration. Cannabis Biotech sought out this eminently Read the full article…